AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Vildanat-M 1000 Tablet SR

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Vildanat-M 1000 Tablet SR

Combiflex-DM 1000mg Extended Release tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex-DM 1000mg ER may be used as monotherapy or in conjunction with other anti-diabetic agents. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. This treatment regulates blood sugar, proactively preventing future complications. Continued adherence to your physician's dietary and exercise plan is crucial. Lifestyle modifications significantly impact diabetes control. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, requires awareness and prompt management. This medication is not universally suitable. Prior to initiating therapy, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate disclosure of all medications to ensure treatment safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of Vildanat-M 1000 Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Vildanat-M 1000 Tablet SR

Managing type 2 diabetes

Major Benefits of Vildanat-M 1000 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vildanat-M 1000 Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. This medication should be administered with a meal.

Common Side effects of Vildanat-M 1000 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildanat-M 1000 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildanat-M 1000 Tablet SR with a meal.

How Vildanat-M 1000 Tablet SR works:

Sustained-release Vildagliptin-Metformin 1000mg tablets combine two agents to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Vildanat-M 1000 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vildanat-M 1000mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Vildanat-M 1000mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildanat-M 1000 SR tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Extended-release Vildanat-M 1000 mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Vildanat-M 1000 Tablet SR :

Should you forget to take a Vildanat-M 1000 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildanat-M 1000 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildanat-M 1000 Tablet SR

Vildanat-M 1000 Tablet SR rarely causes hypoglycemia by itself, but it can if your calorie intake is inadequate. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildanat-M 1000 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without consulting your doctor.
Vildanat-M 1000 Tablet SR is contraindicated in patients allergic to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildanat-M 1000 SR tablets combine metformin (a biguanide) and vildagliptin, both used to treat diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Vildanat-M 1000 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vildanat-M 1000 Tablet SR and seek immediate medical attention.
Prolonged use of Vildanat-M 1000 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildanat-M 1000 Tablet SR is safe when used as directed by your doctor. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vildanat-M 1000 Tablet SR
60
MRP 69
13% off